Target Name: MXRA5
NCBI ID: G25878
Other Name(s): OTTHUMP00000022860 | matrix remodeling associated 5 | MXRA5_HUMAN | Adhesion protein with leucine-rich repeats and Immunoglobulin domains related to perlecan | Matrix remodeling associated 5 | adhesion protein with leucine-rich repeats and Immunoglobulin domains related to perlecan | Adhesion protein with leucine-rich repeats and immunoglobulin domains related to perlecan | Matrix-remodeling-associated protein 5 | adlican | Adlican | matrix-remodelling associated 5 | Matrix-Remodelling Associated 5 | DKFZp564I1922

MXRA5: A Potential Drug Target for Reproductive Biology

MXRA5 (OTTHUMP00000022860) is a protein that is expressed in the human placenta and has been identified as a potential drug target in the field of reproductive biology. The placenta plays a critical role in fetal development and growth, and MXRA5 has been shown to be involved in several important processes that are necessary for this function.

MXRA5 is a member of the TATA-repeat transcription factor family, which is a group of transcription factors that are characterized by the presence of a TATA-repeat sequence in their DNA-binding domain. This family of proteins is known for their ability to regulate gene expression and is thought to play a role in the development and maintenance of tissues and organs during development.

One of the functions of MXRA5 is to regulate the expression of genes that are involved in the development and growth of the placenta. For example, MXRA5 has been shown to play a role in the regulation of the expression of genes involved in cell adhesion and migration , as well as in the production of important signaling molecules that are involved in the development of the placenta.

Another function of MXRA5 is to regulate the production of hormones that are important for fetal growth and development. The placenta is a source of several hormones that are important for fetal growth and development, including progesterone and estrogen. MXRA5 has been shown to play a role in the regulation of the production of these hormones, as well as in the regulation of their effects on the developing fetus.

MXRA5 is also involved in the regulation of the immune system, which is important for the development and growth of the fetal immune system. The placenta is a source of several immune cells that are important for fetal immune development, and MXRA5 has been shown to play a role in the regulation of the production and function of these cells.

In addition to its role in regulating the development and growth of the placenta, MXRA5 is also thought to be involved in the regulation of several other important biological processes that are necessary for fetal development and growth. For example, MXRA5 has been shown to play a role in the regulation of cell signaling pathways that are important for the development of the neural tube, as well as in the regulation of the production of important signaling molecules that are involved in the development of the heart.

Given the important role that MXRA5 plays in the development and growth of the placenta, it is a promising target for drug development. Several studies have shown that MXRA5 can be modulated using various techniques, including RNA interference and small molecule inhibitors. These studies have led to the identification of several potential drug candidates that are currently being evaluated for use in reproductive biology.

While more research is needed to fully understand the role of MXRA5 in the development and growth of the placenta, it is clear that this protein is an important target for drug development. With further research, it is likely that the role of MXRA5 in this important process will be revealed, and it will have a significant impact on the field of reproductive biology.

Protein Name: Matrix Remodeling Associated 5

Functions: In kidney, has anti-inflammatory and anti-fibrotic properties by limiting the induction of chemokines, fibronectin and collagen expression in response to TGB1 and pro-inflammatory stimuli

More Common Targets

MXRA5Y | MXRA7 | MXRA8 | MYADM | MYADML | MYADML2 | MYB | MYBBP1A | MYBL1 | MYBL2 | MYBPC1 | MYBPC2 | MYBPC3 | MYBPH | MYBPHL | MYC | MYCBP | MYCBP2 | MYCBP2-AS1 | MYCBPAP | MYCL | MYCL-AS1 | MYCLP1 | MYCN | MYCNOS | MYCNUT | MYCT1 | MYD88 | MYDGF | MYEF2 | Myelin Protein | MYEOV | MYF5 | MYF6 | MYG1 | MYH1 | MYH10 | MYH11 | MYH13 | MYH14 | MYH15 | MYH16 | MYH2 | MYH3 | MYH4 | MYH6 | MYH7 | MYH7B | MYH8 | MYH9 | MYHAS | MYL1 | MYL10 | MYL11 | MYL12A | MYL12B | MYL12BP3 | MYL2 | MYL3 | MYL4 | MYL5 | MYL6 | MYL6B | MYL7 | MYL9 | MYLIP | MYLK | MYLK-AS1 | MYLK-AS2 | MYLK2 | MYLK3 | MYLK4 | MYLKP1 | MYMK | MYMX | MYNN | MYO10 | MYO15A | MYO15B | MYO16 | MYO16-AS1 | MYO16-AS2 | MYO18A | MYO18B | MYO19 | MYO1A | MYO1B | MYO1C | MYO1D | MYO1E | MYO1F | MYO1G | MYO1H | MYO3A | MYO3B | MYO3B-AS1 | MYO5A | MYO5B | MYO5C | MYO6